Two more pharmaceutical companies — including one with Massachusetts ties — will pay nearly $125 million to settle allegations they encouraged patients to buy their drugs through kickbacks.

Amgen (Nasdaq: AMGN) will pay $24.75 million to settle claims that it incentivized patients to purchase its hyperthyroidism drug Sensipar by funneling money through an outside party to cover customers’ out-of-pocket costs, according to the U.S. Department of Justice. Japanese pharmaceutical company Astellas…

Boston Biz Journal https://www.bizjournals.com/boston/news/2019/04/25/amgen-latest-pharma-to-pay-millions-to-settle-drug.html?ana=RSS&s=article_search